A study of 14,000 Weight Watchers participants is the latest to suggest that Ozempic and similar obesity drugs could be adapted into treatments for substance use disorders.
A study of 14,000 Weight Watchers participants is the latest to suggest that Ozempic and similar obesity drugs could be adapted into treatments for substance use disorders.